Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
Clinical trial NCT00307177 · COMPLETED
Trial details
- NCT number
- NCT00307177
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2005-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.